REFERENCES
- Walker R. B., Smith E. W. The Role of Percutaneous Penetration Enhancers. Adv. Drug Del. Rev. 1996; 18: 295–301
- Wang S., Kara M., Krishnan T. R. Transdermal Delivery of Cyclosporin-A Using Electroporation. J. Controlled Release 1998; 50: 61–70
- Volpato N. M., Nicoli S., Laureri C., Colombo P., Santi P. In Vitro Acyclovir Distribution in Human Skin Layers After Transdermal Iontophoresis. J. Controlled Release 1998; 50: 291–296
- Szejtli J. Medical Applications of Cyclodextrins. Med. Res. Rev. 1994; 14: 353–386
- Loftsson T., Ólafsdóttir B. J., Bodor N. The Effects of Cyclodextrins on Transdermal Delivery of Drugs. Eur. J. Pharm. Biopharm. 1991; 37: 30–33
- Lopez R. F.L., Collett J. H., Bentley M. V.L.B. Influence of Cyclodextrin Complexation on the In Vitro Permeation and Skin Metabolism of Dexamethasone. Int. J. Pharm. 2000; 200: 127–132
- Arima H., Miyaji T., Irie T., Hirayama F., Uekama K. Enhancing Effect of Hydroxypropyl Beta Cyclodextrin on Cutaneous Penetration and Activation of Ethyl 4-Biphenylyl Acetate in Hairless Mouse Skin. Eur. J. Pharm. Sci. 1998; 6: 53–59
- Lin S. Z., Wouessidjewe D., Poelman M. C., Duchêne D. In Vivo Evaluation of Indomethacin/Cyclodextrin Complexes Gastrointestinal Tolerance and Dermal Anti-inflammatory Activity. Int. J. Pharm. 1994; 106: 63–67
- Burnette R. R., Marrero D. Comparison Between the Iontophoretic and Passive Transport of Thyrotropin Releasing Hormone Across Excised Nude Mouse Skin. J. Pharm. Sci. 1986; 75: 738–743
- Ledger P. W. Skin Biological Issues in Electrically Enhanced Transdermal Delivery. Adv. Drug Del. Rev. 1992; 9: 289–307
- Gay C. L., Green P. G., Guy R. H., Francoeur M. L. Iontophoretic Delivery of Piroxicam Across the Skin In Vitro. J. Controlled Release 1992; 22: 57–68
- Hirvonen J., Guy R. H. Iontophoretic Delivery Across the Skin: Electroosmosis and Its Modulation by Drug Substances. Pharm. Res. 1997; 14: 1258–1263
- Chang S. L., Banga A. K. Transdermal Iontophoretic Delivery of Hydrocortisone from Cyclodextrin Solutions. J. Pharm. Pharmacol. 1998; 50: 635–640
- Bhatia K. S., Singh J. Mechanism of Transport Enhancement of LHRH Through Porcine Epidermis by Terpenes and Iontophoresis: Permeability and Lipid Extraction Studies. Pharm. Res. 1998; 15: 1857–1862
- Oh S. Y., Jeong S. Y., Park T. G., Lee J. H. Enhanced Transdermal Delivery of AZT (Zidovudine) Using Iontophoresis and Penetration Enhancer. J. Controlled Release 1998; 51: 161–168
- Ganga S., Ramarao P., Singh J. Effect of Azone on the Iontophoretic Transdermal Delivery of Metoprolol Tartrate Through Human Epidermis In Vitro. J. Controlled Release 1996; 42: 57–64
- Doliwa A., Santoyo S., Ygartua P. Influence of Piroxicam : Hydroxypropyl-Beta-Cyclodextrin Complexation on the In Vitro Permeation and Skin Retention of Piroxicam. Skin. Pharmacol. Appl. Skin. Physiol. 2001; 14: 97–107
- Santoyo S., Ygartua P. Effect of Skin Pre-treatment with Fatty Acids on Percutaneous Absorption and Skin Retention of Piroxicam After Its Topical Application. Eur. J. Pharm. Biopharm. 2000; 50: 245–250
- Singh P., Roberts M. S. Skin Permeability and Local Tissue Concentration of Nonsteroidal Anti-inflammatory Drugs After Topical Application. J. Pharmacol. Exp. Ther. 1994; 268: 144–151
- Tenjarla S., Puranajoti P., Kasina R., Mandal T. Preparation, Characterization, and Evaluation of Miconazole-Cyclodextrin Complexes for Improved Oral and Topical Delivery. J. Pharm. Sci. 1998; 87: 425–429
- Vollmer U., Müller B., Wilffert B., Peters T. An Improved Model for Studies on Transdermal Drug Absorption In-Vivo in Rats. J. Pharm. Pharmacol. 1993; 45: 242–245
- Legendre J. Y., Rault I., Luijten W., Demuynck I., Horvath S., Ginot Y. M., Cuine A. Effects of Cyclodextrins on Skin: Implications for the Transdermal Delivery of Piribedil and a Novel Cognition Enhancing-Drug. Eur. J. Pharm. Sci. 1995; 3: 311–322
- Vitória M., Bentley L. B., Vianna R. F., Wilson S., Collett J. H. Characterization of the Influence of Some Cyclodextrins on the Stratum Corneum from the Hairless Mouse. J. Pharm. Pharmacol. 1997; 49: 397–402